This week, Dr. Osterholm offers his perspective on COVID mitigation strategies in schools, the new antiviral drug molnupiravir, the unpredictability of the upcoming flu season, and optimism after receiving his booster shot.
Email us your questions at <a href="mailto:OsterholmUpdate@umn.edu">OsterholmUpdate@umn.edu</a> 
From &#039;heroes to villains&#039;: Why this Covid surge is different for health care workers: 
<a href="https://www.nbcnews.com/news/us-news/health-care-workers-went-heroes-villains-rcna2559">https://www.nbcnews.com/news/us-news/health-care-workers-went-heroes-vi…</a>
Transcript available here: <a href="https://www.cidrap.umn.edu/ep-72-transcript">https://www.cidrap.umn.edu/ep-72-transcript</a>
Donate now for CIDRAP&#039;s 20th anniversary: <a href="https://www.cidrap.umn.edu/donate">https://www.cidrap.umn.edu/donate</a>

Osterholm Update

Episode 72: A Surge in Optimism

A weekly report on the COVID-19 pandemic from infectious disease expert Michael Osterholm, PhD, MPH. Dr. Osterholm is the director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota and has spent a career investigating outbreaks. Since 2005, he has emphasized supply chain and other vulnerabilities and a critical need for pandemic preparedness. In this podcast, Dr. Osterholm dissects the latest COVID-19 news, data, and guidance.
CIDRAP’s Chris Dall, MA, is the cohost of the Osterholm Update and a reporter for CIDRAP News. http://www.cidrap.umn.edu
